- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| Di | Bluejay Diagnostics raises $8.5M in private placement | 1 | Investing.com | ||
| Di | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| Di | Why Is Bluejay Diagnostics Stock Soaring Tuesday? | 7 | Benzinga.com | ||
| Di | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | 255 | AFX News | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Di | Bluejay Diagnostics partners with Argonaut for US manufacturing | 4 | Investing.com | ||
| Di | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 124 | GlobeNewswire (Europe) | ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing... ► Artikel lesen | |
| Di | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | 104 | GlobeNewswire (Europe) | ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings... ► Artikel lesen | |
| 07.05. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial | 216 | GlobeNewswire (Europe) | ACTON, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on rapid, near-patient testing, today announced the successful... ► Artikel lesen | |
| 16.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.03. | Bluejay Diagnostics, Inc.: Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 06.03. | Bluejay Diagnostics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook | 199 | GlobeNewswire (Europe) | ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical diagnostics company developing rapid near-patient tests to improve... ► Artikel lesen | |
| 20.02. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.02. | Bluejay Diagnostics meldet vollständige Ausübung vorausfinanzierter Optionsscheine | 1 | Investing.com Deutsch | ||
| 20.02. | Bluejay Diagnostics completes prefunded warrant exercises | 2 | Investing.com | ||
| 20.02. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 26,100 | 0,00 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| HIMS & HERS HEALTH | 23,580 | -0,34 % | Telemedizin-Aktie legt zu: 1,15-Milliarden-Deal: Hims & Hers expandiert radikal | © Foto: picture alliance / ZUMAPRESS.com | Avishek DasHims & Hers kauft sich mit Eucalyptus in neue Märkte ein - der Milliarden-Deal schürt Fantasie für den nächsten Wachstumsschub.Hims & Hers Health... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 53,18 | -0,23 % | NordicNeuroLab and GE HealthCare Enter Strategic Software License and Distribution Agreement to Advance Neuroimaging Worldwide | A collaboration for advancing neuroimaging MILWAUKEE, WI / ACCESS Newswire / May 27, 2026 / NordicNeuroLab announced the signing of a comprehensive Software License and Distribution Agreement with GE... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,280 | +1,86 % | Jim Cramer on Clover Health: "You're in Pure Spec Mode There" | ||
| PICARD MEDICAL | 0,270 | -2,04 % | PICARD MEDICAL, INC. Issues Letter to Shareholders | TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and... ► Artikel lesen | |
| FRESENIUS | 36,450 | 0,00 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| FRESENIUS MEDICAL CARE | 35,690 | 0,00 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,34 | 0,00 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| ALIGNMENT HEALTHCARE | 13,640 | 0,00 % | Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report | ||
| SIEMENS HEALTHINEERS | 34,040 | 0,00 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,760 | 0,00 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 25,115 | -0,02 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| GENEDX | 53,07 | -0,11 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 94,01 | -0,25 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| QTREX QUANTUM | 2,415 | +4,09 % | QTREX Quantum Ltd.: QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston |
BLUEJAY DIAGNOSTICS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,69 % bei einem Aktienkurs von 4,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BLUEJAY DIAGNOSTICS INC finden Sie auf Wallstreet Online.